Marwah Medicine

Medical

Meet the new detective of the nerve world: MRI Neurography!

Handling patients with Prolapsed intervertebral disc and offering them gabapentin for years is what we are doing for decades now. Have you ever wished you could literally follow a nerve along its winding path and catch it in the act of being compressed, inflamed, or injured? Well, MRI Neurography does just that—it’s like Sherlock Holmes for your nervous system! While traditional MRI is great for bones, muscles, and brain tissue, it often misses the subtle screams of your peripheral nerves. That’s where MRI Neurography swoops in like a superhero with a magnifying glass, zooming into every twist and turn of the nerve. Just think of it like switching from a grainy black-and-white TV to full-blown 4K ultra-HD for your nerves. What Exactly Is MRI Neurography? MRI Neurography is a cutting-edge imaging technique that allows doctors to visualize nerves with incredible clarity—especially the peripheral nerves, like the sciatic nerve, brachial plexus, or facial nerve. It uses high-resolution MRI sequences to highlight nerves and distinguish them from nearby muscles, vessels, and fat. This technique uses T2-weighted images with fat suppression, and often 3D STIR (Short Tau Inversion Recovery) sequences, to make abnormal nerves light up like glow sticks in a dark room. If there’s swelling, fibrosis, or compression—it’ll show up. In short MRI Neurography is the best modality for visualizing peripheral nerve disorders—especially in cases where EMG/NCV or standard MRI gives inconclusive results. From catching a tiny nerve root avulsion to highlighting a subtle perineural mass, this technique changes the game in neurology, orthopaedics, and pain medicine. When Do We Use MRI Neurography? If someone’s struggling with unexplained pain, numbness, tingling, or weakness—and standard MRI or EMG just isn’t giving answers—MRI Neurography is the go-to move. Clinical Indications for MRI Neurography   Example Use case Branchial or lumbosacral plexopathy   Post traumatic or radiation induced plexus injury Nerve entrapment syndrome   Carpal tunnel or piriformis syndrome Nerve trauma Sciatica or radial nerve damage   Nerve sheath tumours Schwannoma or neurofibroma   Chronic neuropathies Diabetic neuropathy, CIDP     Procedural details Patients lie in a standard MRI machine, but the software sequences are different. Special coils and 3D fat-suppressed images are used. Often, a contrast agent like Gadolinium is given to light up inflammatory or neoplastic areas. And voila—those nerves are on full display! Take home message: MRI neurography superiority over MRI in lieu 1.      Nerve visualization 2.      Nerve inflammation 3.      Anatomical reconstruction 4.      Clinical specificity    

NEET PG

Example Post for WordPress

This is a sample post created to test the basic formatting features of the WordPress CMS. Subheading Level 2 You can use bold text, italic text, and combine both styles. Bullet list item #1 Item with bold emphasis And a link: official WordPress site Step one Step two Step three This content is only for demonstration purposes. Feel free to edit or delete it.

Medical, NEET PG

Motor neuron disease and amyotrophic lateral sclerosis

In this post we’ll break down the major types of MNDs, compare their clinical features and highlight points crucial for competitive exams like NEET PG, INI-CET, and FMGE. Core issue is combination of UMN and LMN lesion findings coexistent in a same patient for ALS. Physicist Stephen hawking was the longest living survivor of this fatal disorder that ultimately causes demise due to diaphragmatic paralysis. As bonus tip learn differences between AIDP and CIDP in 2 minutes at the bottom of this article. Comparison of Major Motor Neuron Disease  Disease  UMN involvement  LMN involvement  Key features  Onset & Progression  Age of Onset  Prognosis  Amyotrophic lateral Sclerosis (ALS) √ √ Mixed signs: spasticity + fasciculations; bulbar signs common Gradual onset, relentless progression 40-70 years Fatal within 3-5 years ( respiratory failure) Primary Lateral Sclerosis  √ X Pure UMN signs: spasticity, hyperreflexia, Babinski sign: no fasciculations Very slow progression >50 years Relatively benign Progressive muscular Atrophy (PMA) X √ Pure LMN signs; muscle wasting, fasciculations, flaccid weakness Gradual 30-60 years Better than ALS but can evolve into ALS Spinal muscular Atrophy (SMA) X √ Symmetrical LMN weakness, hypotonia, tongue fasciculations (esp. in infants) Depends on type (infantile to adult) Infancy to adulthood Varies (SMA type I is fatal in infancy) Progressive Bulbar Palsy  √ (bulbar UMNs) √ (bulbar LMNs) Dysarthria, dysphagia, tongue atrophy, emotional lability Often progresses to ALS 40-70 years Poor Pseudobulbar Palsy  √ X Dysarthria, dysphagia, emotional lability, but no tongue wasting or fasciculations Often associated with bilateral stroked / MS Older adults Variable   Key Clinical Differences  ALS (Amyotrophic lateral sclerosis) Hallmark: Combination of UMN and LMN signs in multiple regions Buzzwords: Fasciculations + spasticity: tongue atrophy; split hand sign PLS (Primary Lateral Sclerosis)  Hallmark: Pure UMN involvement Clue: No Fasciculations or muscle wasting PMA ( Progressive Muscular Atrophy Hallmark: Pure LMN disease Buzzwords: Muscle atrophy, areflexia, fasciculations, no spasticity May progress to ALS over time. SMA (Spinal Muscular Atrophy)  Genetics: Autosomal recessive, SMN1 gene mutation Types: Type I (Werdnig-Hoffmann): Infantile, floppy baby, fatal in 1st year Type II: Childhood onset Type III: (Kugelberg-Welander): Adolescent / adult onset Type: IV: Adult form, mildest   Progressive Bulbar Palsy Vs Pseudobulbar Palsy  Feature  Progressive Bulbar  Pseudobulbar  Site CN IX – XII (LMN) UMN to bulbar nuclei Tongue Atrophy, fasciculations Small spastic, no atrophy Reflexes Absent gag reflex Exaggerated jaw jerk Emotional lability Present Present Association May be variant of ALS Often bilateral strokes /MS   Important Exam Points  Most common MND: ALS ALS Affects both UMN and LMN – a key distinguishing feature Fasciculations + spasticity: Think ALS Tongue fasciculations in infants: Think SMA type I No sensory involvement is typical in MNDs. Frontotemporal dementia may coexist with ALS (especially C9 or F72 mutation) Riluzole is the only FDA – approval drug for ALS – prolongs survival by ~3 months. Recent Advances  Risdiplam for SMA Type: Oral SMN2 splicing modifier Mechanism: Increases production of functional SMN protein via enhanced SMN2 splicing Route: Oral syrup taken daily Age: Approved for infants (>2 months), children, and adult Gene therapy for SMA (Type I) with nusinersen and onasemnogene abeparvovec has revolutionized prognosis in children. Edaravone has been added as a treatment option in some ALS cases.   Bonus Tip  Comparison: AIDP vs CIDP Feature AIDP (Acute Inflammatory Demyelinating Polyradiculoneuropathy) CIDP (chronic Inflammatory Demyelinating Polyradiculoneuropathy)  Full form  Acute inflammatory demyelinating polyradiculoneuropathy Chronic Inflammatory Demyelinating Polyradiculoneuropathy Type  Most common variant of GBS Chronic form Onset Acute (subtype of GBS) Chronic (≥ weeks) Progression  Rapid (Similar to GBS) Slowly progressive or relapsing Weakness Ascending symmetric Similar but slower, often proximal and distal Reflexes  Absent or decreased Absent or decreased CSF Same as GBS Same ( mildly elevated protein, low WBC) Nerve Conduction  Demyelinating Demyelinating Treatment  IVIG or plasmapheresis Steroids IVIG, plasmapheresis (long -term)  

Medical, NEET PG

Irritable bowel Syndrome (IBS): A Practical Guide for Clinicians

Irritable Bowel Syndrome (IBS) is one of the most common functional gastrointestinal disorders encountered in clinical practice, yet it remains a diagnosis of exclusion and often misunderstood. It affects 10-15% of the global population, disproportionately impacting quality of life while posing a diagnostic challenge due to symptom overlap with inflammatory bowel disease (IBD). In this post, we’ll explore the pathophysiology, clinical features, diagnosis, and treatment of IBS with a special focus on dietary interventions (FODMAPs) and pharmacological options for IBS-C (constipation – predominant) and IBS-D (diarrhea- predominant) variants. We’ll also clarify key differences between IBS and IBD, a common source of confusion in clinical settings. What is IBS? IBS is chronic functional GI disorder characterized by recurrent abdominal pain associated with altered bowel habits, in the absence of any identifiable structural or biochemical cause. Rome IV Criteria: Recurrent abdominal pain, on average, at least 1 day/week in the last 3 months, associated with ≥ of the following: Related to defection Change in frequency of stool Change in form (appearance) of stool How to asses appearance of stool? Use Bristol stool chart as shown below Symptom onset must be at least 6 months before diagnosis. IBS vs IBD: A common Confusion Feature IBS IBD (Crohn’s /Ulcerative Colitis)   Nature Functional disorder Organic, inflammatory disease Pathology No mucosal inflammation or ulcers Mucosal inflammation, ulceration Colonoscopy Normal Abnormal (ulcers, erythema, pseudo-polyps) Histology Normal Inflammatory infiltrates, granulomas CRP/Fecal Calprotectin Normal Elevated Red flag signs Absent May have blood in stool, weight loss Risk of colon cancer No increased risk Increased risk   Clinical pearl: Always rule out IBD, colorectal cancer, and celiac disease before labeling a patient with IBS – especially in patients >50 or with alarming symptoms like weight loss, rectal bleeding or nocturnal symptoms. Pathophysiology of IBS IBS is multifactorial and still not fully understood. Key contributing factors include: Visceral hypersensitivity Altered gut motility Gut-brain axis dysfunction Post – infectious changes Microbiota alterations Psychological stressors ( anxiety / depression) Role of Diet: FODMAPs Explained Many patients with IBS report food -related triggers. The low FODMAP Diet is a central dietary intervention. What are FODMAPs? FODMAP= Fermentable Oligosaccharides, Disaccharides, Monosacchrides, and Polyols. These are short chain carbohydrates poorly absorbed in the gut and rapidly fermented by colonic bacteria, causing bloating, gas, and diarrhea. High FODMAP foods: Oligosaccharides: Wheat, rye, onions, garlic Disaccharides: Milk, yogurt (lactose) Monosaccharide: Apples, Honey (excess fructose) Polyols: Sorbitol, mannitol (found in artificial sweeteners, some fruits) Approach: Elimination phase: 4-6 weeks of low FODMAP intake Rechallenge phase: Gradual reintroduction to identify specific triggers Maintenance phase: Personalized, less restrictive diet Evidence supports the low FODMAP diet in reducing global IBS symptoms, particularly bloating and abdominal pain. Pharmacological Management Tailored according to predominant symptoms: IBS – C (Constipation – Predominant) Drug/ Class Mechanism Notes Fiber (e.g. psyllium) Bulking agent Soluble fiber preferred over insoluble PEG (Polyethylene glycol) Osmotic laxative First- line for many patients Lubiprostone Chloride channel activator (CIC-2) Increases intestinal fluid secretion Linaclotide Guanylate cyclase – C agonist Enhances fluid secretion and motility Prucalopride 5-HT4 receptor agonist Promotility agent; used selectively   Pro tip: Avoid stimulant laxatives long-term duet to potential for tolerance and cathartic colon. IBS – D (Diarrhea- Predominant) Drug/ Class Mechanism Notes Loperamide µ-opioid receptor agonist Symptomatic relief only; does not relieve pain Alosetron 5-HT3 antagonist Used in woman with severe IBS-D; rare ischemic colitis risk Rifaximin Non-absorbable antibiotic Useful in IBS-D with bloating; 2-week course Bile acid sequestrants Binds bile acids (e.g. cholestyramine) For patients with bile acid malabsorption Eluxadoline Mixed opioid receptor modulator Avoid in patients without gallbladder or with pancreatitis risk   For pain and global symptoms Drug/ Class Role Antispasmodics Relieve abdominal cramps (e.g. dicyclomine, hyoscine) Tricyclic Antidepressants (TCAs) Modulate pain and motility (e.g. amitriptyline) SSRIs/SNRIs For patients with predominant anxiety or depression Cognitive Behavioral Therapy (CBT) Especially effective in refractory cases   Red Flag Symptoms (NOT typically of IBS) Always investigate further if any of these are present: Age >50 with new onset symptoms Nocturnal diarrhea Unintentional weight loss Rectal bleeding Iron – deficiency anemia Family history of colorectal cancer or IBD   Summary Table: IBS subtypes and management Subtype Key Features First – line Management IBS-C Pain + infrequent, hard stools Fiber, PEG, linaclotide IBS- D Pain +frequent, loose stools Loperamide, rifaximin IBS- M Mixed symptoms Symptom – directed approach IBS-U Unclassified Supportive, individualized   “The art of IBS management is not in curing, but in relieving symptoms, validating patient concerns, and enhancing quality of life.”

INICET, Medical, Medicine classes, NEET PG

Hypokalemic vs. Hyperkalemic periodic paralysis – High Yield NEET PG & INI – CET guide

Why This Topic is Important for NEET PG & INI-CET Periodic paralysis disorders are commonly tested in NEET PG and INI-CET. A solid grasp of hypokalemic and hyperkalemic periodic paralysis will help in answering questions correctly. These conditions involve ion channel activity  affecting muscle function, leading to temporary paralysis. Let’s break it down in a high-yield, exam -focused manner. What is periodic paralysis? Periodic paralysis refers to rare neuromuscular disorders characterized by episodes of muscle weakness or paralysis triggered by fluctuation in serum potassium levels.  The two main types are mentioned in the tabular format highlighting key differences. Mnemonic to remember “HYPO has HIGH triggers, HYPER has Low Triggers” HYPO Kalemic Paralysis = HIGH Sugar & Carb intake causes an attack . HYPER Kalemic paralysis = LOW Food intake (Fasting) triggers the episode. Key differences – High – Yield Table Feature Hypokalemic Periodic Paralysis Hyperkalemic Periodic paralysis Cause Mutation in CACNA1S/SCN4A gene Primary answer as calcium channel defect Mutation in SCN4A gene Primary answer as sodium channel defect Serum potassium during attack Low (<3.5 mEq/L) High (>5.0 mEq/L) Triggers High -carb meals, exercise, stress Fasting, rest after exercise Onset Teenage years (10-20 years) Early childhood Duration of Attack Hours to days Minutes to hours Reflexes Reduced Normal Treatment Potassium supplementation, avoiding triggers Glucose, diuretics (thiazides)   Clinical cases to remember Hypokalemic Periodic Paralysis Hyperkalemic Periodic Paralysis A 15-year-old male wakes up with sudden muscle weakness after eating a large pizza and soda the previous night Blood tests show low serum potassium ( 2.5 mEq/L) A 6-year-old child experiences muscle weakness after skipping breakfast. Symptoms resolve spontaneously after a few hours. Blood tests show elevated potassium ( 5.6 mEq/L).   Diagnosis & Investigations Serum potassium levels during an attack Electromyography (EMG): Shows myotonic discharges in Hyper PP Genetic testing: Confirms mutations in SCN4A (Hyper PP) and CACNA1S/SCN4A (Hypo PP) Exercise Test: Potassium levels drop in Hypo PP and rise in Hyper PP   Treatment Approach – High Yield Table Condition Acute attack Management Long-Term prevention Hypokalemic PP Oral /IV potassium Avoid high-carb meals, Acetazolamide Hyperkalemic PP Glucose + insulin, diuretics Low potassium, diet, acetazolamide   Exam Pearls – Must – Know for NEET PG & INI- CET Hypokalemic PP is often linked to thyrotoxic periodic paralysis – commonly seen in Asian populations. Hyperkalemic PP is associated with myotonia (delayed muscle relaxation after contraction). Acetazolamide is used in both conditions as it stabilizes ion channels but can worsen type 2 RTA.   📌Related High – Yield Topics to Read click on this link https://marwahmedicine.com/newsite/blogs/ Suggested reading for doctors sitting for NEET PG and INICET examination from these blog posts 📌Barrter vs. Gitelman syndrome 📌 Renal Tubular Acidosis 📌 Electrolyte disorders – Quick Mnemonics& Cases

INICET, Medical, NEET PG

EPILEPSY

If you are looking for a quick reference table for all types of epilepsy, clinical features, EEG findings and First line drug this is the post that you have to save to your device.  This is followed by a video tutorial and then 5 MCQ with long options mimicking what happens in entrance exams like NEET PG and INICET examinations. Types of Epilepsy Types of Epilepsy Cause Clinical presentation EEG findings Drug of Choice (DOC) Generalized Tonic clonic Seizure (GTCS) Often idiopathic or genetic Sudden LOC followed by Tonic stiffening clonic jerks Postictal confusion Generalized high amplitude poly-spike & slow waves Valproate (Alt: Lamotrigine, levetiracetam) Absence Seizure Idiopathic (childhood onset) Brief staring spells, no postictal confusion, may be frequent Classic 3 Hz spike-and -wave discharges, generalized and symmetrical Ethosuximide (Alt; valproate ) Myoclonic Seizure Juvenile Myoclonic Epilepsy Sudden brief jerks, often in morning; preserved awareness 4-6 Hz polyspike and wave discharges Valproate (Alt; Levetiracetam) Atonic Seizure Often part of Lennox – Gastuat syndrome Sudden loss of muscle tone → falls (“drop attacks”) Slow spike-and -wave complex <2.5 Hz Valproate (Alt: Rufinamide, clobazam) Infantile Spasms West syndrome (TS, hypoxia, infections) Clusters of sudden flexor/extensor spasms; developmental delay Hypsarrhythmia; chaotic high -voltage slow waves & spikes ACTH (1st line) (Alt:vigobatrin if Tuberous sclerosis) Focal Seizure without impaired awareness Cortical lesion, trauma, stroke, infection Motor/sensory symptoms without impaired consciousness Focal spikes or sharp waves at seizures focus Carbamazepine (Alt: oxcarbazepine) Focal seizure with impaired awareness Same as above Aura →impaired consciousness→ automatisms (e.g. lip smacking) Interictal temporal spikes/sharp waves Carbamazepine Alt: Lamotrigine) Status Epilepticus Non – compliance, metabolic, trauma Seizure lasting > 5 min or repeated without recovery Continuous epileptiform activity or periodic discharges Lorazepam (acute) followed by IV Phenytoin drip or IV Valproate   Now you can go practical aspects and watch simulation from the following videos. This will help you understand the nuances of this table relatively better. https://www.youtube.com/watch?v=s4rxG1Ho8L8   Here are 5 NEET PG/INI-CET–style clinical questions on Epilepsy, with long and tricky options, followed by correct answers and brief explanations: Question 1 A 25-year-old male presents with a history of recurrent seizures characterized by sudden behavioral arrest, lip-smacking, and fumbling movements of the hands lasting about 1–2 minutes, followed by confusion and disorientation. MRI reveals hippocampal sclerosis. Which of the following is the most appropriate treatment option for long-term management? A. Continue valproate and phenytoin combination therapy with periodic dose adjustments and monitor for hepatic and hematologic toxicity B. Add clobazam to ongoing carbamazepine therapy to achieve better seizure control without planning for surgical options C. Refer for anterior temporal lobectomy after appropriate video EEG and neuroimaging evaluation, as drug resistance is likely D. Switch to levetiracetam monotherapy and monitor response for 12 months before considering invasive procedures Correct Answer: C. Refer for anterior temporal lobectomy after appropriate video EEG and neuroimaging evaluation, as drug resistance is likely Explanation: The patient has features of mesial temporal lobe epilepsy (MTLE), likely drug-resistant, especially with hippocampal sclerosis. Surgery (anterior temporal lobectomy) is the treatment of choice in refractory cases. Question 2 A 7-year-old child is brought to the clinic with a history of frequent brief episodes where she stops talking, stares into space for a few seconds, and then resumes activity as if nothing happened. EEG shows 3 Hz spike-and-wave discharges. Which of the following is the most appropriate first-line treatment? A. Carbamazepine, which is highly effective for generalized and focal seizures including absence B. Phenytoin, as it has broad-spectrum activity with minimal behavioral side effects in children C. Ethosuximide, as it is particularly effective for absence seizures and well tolerated D. Lamotrigine, which is preferred over valproate due to its favorable safety profile in young children Correct Answer: C. Ethosuximide, as it is particularly effective for absence seizures and well tolerated Explanation: Typical absence seizures respond best to ethosuximide. Valproate is also effective but used when generalized seizures coexist. Carbamazepine can worsen absence seizures.  Question 3 A 60-year-old male with a history of focal seizures develops a generalized tonic-clonic seizure in the emergency department that continues for over 5 minutes without regaining consciousness. IV access is available. What is the next best step in management? A. Administer IV phenytoin loading dose and wait 20 minutes before considering benzodiazepines Immediate administration of IV lorazepam followed by IV phenytoin to abort status epilepticus C. Secure airway and give IV mannitol before starting anti-epileptic treatment to prevent raised ICP D. Administer oral levetiracetam through nasogastric tube if IV lorazepam is unavailable  Correct Answer: B. Immediate administration of IV lorazepam followed by IV phenytoin to abort status epilepticus Explanation: Generalized convulsive status epilepticus (GCSE) requires benzodiazepines first (IV lorazepam), followed by a long-acting agent like phenytoin or valproate. Question 4 A 30-year-old woman with epilepsy is planning pregnancy. She is currently on valproate monotherapy with good seizure control. What is the best strategy in this case? A. Continue valproate and add folic acid 5 mg/day to reduce neural tube defect risk B. Switch to lamotrigine before conception as it has a lower teratogenic risk and is effective C. Stop all antiepileptic drugs before conception and monitor EEG to reduce fetal risk D. Add carbamazepine to valproate to lower the required dose of each and minimize side effects Correct Answer: B. Switch to lamotrigine before conception as it has a lower teratogenic risk and is effective Explanation: Valproate is highly teratogenic, especially causing neural tube defects. Lamotrigine is safer in pregnancy. Ideally, switch medications before conception.  Question 5 A 17-year-old male presents with early morning myoclonic jerks, especially soon after waking, and occasional generalized tonic-clonic seizures. He has no focal neurological deficits, and EEG shows generalized polyspike-and-wave discharges. Which of the following is the most likely diagnosis? A. Juvenile myoclonic epilepsy, a generalized epilepsy syndrome with excellent prognosis and good response to valproate B. Lennox-Gastaut syndrome, a severe childhood-onset epilepsy with tonic seizures, cognitive decline, and poor prognosis C. Benign rolandic epilepsy, a childhood epilepsy with focal seizures involving the face and normal development D. […]

INICET, NEET PG

Serum Albumin Ascites Gradient

SAAG value assessment is a common topic asked in NEET PG and INICET. Here is a quick table to remember causes of high SAAG ascites > 1.1 gm / dl . most of the time the question will be on early or late Budd Chiari syndrome. Go crush this in next 30 seconds. Mnemonic: CHIMP  

INICET, NEET PG, NEET PG 2025

Triple therapy in respiratory system: Must Know for NEET PG and INICET aspirants

Triple therapy term is used in management of pulmonary artery hypertension, COPD and cystic fibrosis. Let us now read in next 2 minutes a quick recap of this must asked topic for your forthcoming competitive examinations. Triple Therapy for Pulmonary Arterial Hypertension (PAH) Endothelin Receptor Antagonists (ERAs) Example: Bosentan, Ambrisentan, Macitentan Action: Blocks endothelin, a vasoconstrictor, to reduce pulmonary vascular resistance. Phosphodiesterase-5 (PDE-5) Inhibitors or Soluble Guanylate Cyclase (sGC) Stimulators Example (PDE-5): Sildenafil, Tadalafil Example (sGC stimulator): Riociguat Action: Increases nitric oxide (NO) signaling to promote vasodilation. Prostacyclin Analogues or Prostacyclin Receptor Agonists Example: Epoprostenol, Treprostinil, Selexipag Action: Mimics prostacyclin to dilate blood vessels and inhibit platelet aggregation. This combination targets multiple pathways involved in PAH pathophysiology, offering better control of the disease. Triple Therapy for COPD Triple therapy for Chronic Obstructive Pulmonary Disease (COPD) involves a combination of inhaled medications to manage symptoms and reduce exacerbations. Long-Acting Beta-2 Agonists (LABA) Example: Salmeterol, Formoterol, Indacaterol Action: Broncho dilates airways for symptom relief and improved airflow. Long-Acting Muscarinic Antagonists (LAMA) Example: Tiotropium, Glycopyrrolate, Umeclidinium Action: Reduces bronchoconstriction by blocking muscarinic receptors in the airways. Inhaled Corticosteroids (ICS) Example: Budesonide, Fluticasone, Beclomethasone Action: Reduces airway inflammation and frequency of exacerbations. Triple therapy (LABA + LAMA + ICS) is recommended for patients with moderate to severe COPD who have frequent exacerbations despite dual therapy. Triple Therapy for Cystic Fibrosis (CF) For patients with Cystic Fibrosis, triple therapy specifically refers to the combination of CFTR modulators targeting different aspects of the CFTR protein defect (commonly associated with the F508del mutation). Elexacaftor Action: Facilitates the movement of defective CFTR protein to the cell surface. Tezacaftor Action: Improves CFTR protein processing and stability. Ivacaftor Action: Potentiates the function of the CFTR protein at the cell surface, enhancing chloride ion transport. This combination therapy significantly improves lung function and quality of life in CF patients with the F508del mutation. For more insightful information keep this page bookmarked. You can also check out this link https://marwahmedicine.com/newsite/bartter-syndrome-vs-gitelman-syndrome-a-must-know-topic-for-neet-pg-ini-cet-aspirants/

INICET, NEET PG, NEET PG 2025

Bartter Syndrome vs. Gitelman Syndrome: A Must-Know Topic for NEET PG & INI-CET Aspirants

When preparing for NEET PG and INI-CET, mastering renal tubular disorders is crucial. Among these, Bartter Syndrome and Gitelman Syndrome are frequently tested due to their importance in clinical practice. Understanding their pathophysiology, clinical presentation, and lab findings with precision is essential for scoring high in medical entrance exams. Pathophysiology in a Nutshell Bartter Syndrome mimics the effect of chronic loop diuretics (e.g., furosemide), leading to salt-wasting and hypokalemia. Gitelman Syndrome mimics thiazide diuretics, causing hypokalemia, hypomagnesemia, and hypocalciuria. Clinical Case Example Case 1 Case 2 A 3-month-old infant presents with failure to thrive, polyuria, and hypokalaemia. Urinary calcium is high. Think Bartter Syndrome 15-year-old presents with muscle cramps, fatigue. Labs show hypokalaemia, hypomagnesemia and low urinary calcium. Think Gitelman Syndrome.   These clinical and biochemical differences should be memorized thoroughly to answer exam questions accurately. Bookmark this page on marwahMedicine.com for your last-minute revision!

Medical

Alzheimer Disease vs Dementia with Lewy Bodies

Dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD) have overhanging features but can be differentiated based on clinical, cognitive, and imaging characteristics. This topic is always asked in NEETPG and INICET exams and hence these tables provide valuable 5-minute read that will help you ace this question like a champion   Clinical Features Features DLB AD Cognitive Decline Fluctuating cognition with pronounced variations in attention and alertness Gradual and steady decline, primarily affecting memory Hallucinations Early and well formed visual hallucinations Late and less prominent hallucinations Parkinsonism Early -onset (within 1 year of cognitive symptoms), mild, with bradykinesia and rigidity Late – onset or absent REM sleep behavior disorder (RBD) Common and often precedes cognitive symptoms Rare Autonomic dysfunction Frequent (orthostatic hypotension, urinary incontinence) Less common and occurs later Neuroleptic sensitivity Severe sensitivity to antipsychotics Generally absent   Cognitive profile   DLB: Early deficits in attention, visuospatial skills, and executive function, with relatively preserved memory. AD: Early impairment in episodic memory, progressing to language, visuospatial, and executive dysfunction.   Imaging features: Modality DLB AD MRI Relative preservation of medial temporal lobe Hippocampal and medial temporal atrophy DaT scan (SPECT) Reduced dopamine transporter uptake in basal ganglia Normal FDG – PET Occipital hypometabolism Temporal parietal hypometabolism   Biomarkers  Biomarker DLB AD CSF (Ab & tau levels) May have normal or slightly altered Ab/tau ratio ¯Ab42, ↑ total tau and phosphor-tau α-synuclein pathology Present (Lewy bodies in cortex) Absent   Response to cholinesterase inhibitors DLB: Good response, but may worsen tremors AD: Modest improvement in cognition

Scroll to Top